Clinical Trials & Pipeline
News & Events
Mirna is a clinical stage biopharmaceutical company developing a broad pipeline of leading microRNA-based oncology therapeutics, the first to be tested in cancer patients.
LEARN MORE ABOUT US
MRX34, Mirna’s lead product candidate, is the first microRNA mimic to enter clinical testing.
LEARN MORE ABOUT OUR CLINICAL TRIALS AND PIPELINE
June 10, 2014
Mirna Therapeutics Announces First Patient Enrolled in Hematological Malignancy Cohort of its Phase 1 Clinical Trial
April 8, 2014
Mirna Therapeutics Announces Interim Phase 1 Safety Data on Lead Product Candidate MRX34 at AACR Annual Meeting
VIEW ALL NEWS
© 2014 Mirna Therapeutics, Inc. All Rights Reserved.